Chulalongkorn University: ChulaCov19
Vaccine Type: RNA
This vaccine may also be referred to as ChulaCov19-US
Vaccine Trial & Approval Tracker
-
Phase 1
-
Phase 2
-
Phase 3
-
Approved
This vaccine has reached Phase 2 trials.
About Trial Phases
Phase 3:
0
Trials
There are no trials for this phase.
Approvals
This vaccine is not yet approved.
Registered Trials
-
NCT05605470
Phase 2
Australia
Total Enrollment: 150
Official Trial Registration:
-
NCT05231369
Phase 1/2
Thailand
Total Enrollment: 60
Official Trial Registration:
-
NCT04566276
Phase 1/2
Thailand
Total Enrollment: 96
Official Trial Registration:
